University of Campania
Naples, 80100, Italy
NCT Number: NCT05729776
In previous study the investigators proved that blood glucose after eating pizza margherita could be managed with a simple wave bolus of insulin in pediatric patients with type 1 diabetes under controlled conditions. Participants in this previous study were Predictive Low Glucose Suspended (PLGS) System users. In this study the investigators want to demonstrate that blood glucose after the meal pizza margherita could also be managed with simple wave bolus of insulin in real life. The investigators will include just the patients with Hybrid Closed Loop (HCL) System.
Looking for future studies?
Notify Me8 year–18 year
All sexes
Observational
Naples, 80100, Italy
The investigators will enroll all patients with type 1 diabetes using of Hybrid Closed Loop (HCL) Systems (Medtronic MiniMed 780 G insulin pump system, Tandem T: Slim X2 insulin pump) followed in a diabetes center. The patients aged between 8- 18 will be included in the study just in a condition of using HCL Systems at least 3 months. Patients with HbA1c >8.5 % (69 mmol/mol), celiac disease, other food allergies will be excluded. The investigators will ask to parents feeding children with a pizza margherita which contains 100 grams of carbohydrates. Even if the patients could choose to consume pizza in different restaurants, the investigators will suggest having the pizza prepared with 200 grams of dough (which contains about 100 grams of carbohydrate). To validate the results the investigators will compare, for each patient, the data of glucose sensor and insulin pump after pizza consumption with those resulting from the consumption of a meal with the same macronutrient content. Patients should not consume anything else for 12 hours after the pizza (and after the meal containing the same macronutrient content). For this reason, patients will be encouraged to have these meals for dinner.
The aim of the study is comparing pizza with another meal which contains similar macronutrients. Second goal of this study is evaluating the blood glucose profile after eating pizza comparing the competency of two different Hybrid Closed Loop (HCL) Systems (Medtronic MiniMed 780 G insulin pump system, Tandem T: Slim X2 insulin pump) to manage blood glucose after eating pizza.
The investigators will collect data from both Carelink (for Medtronic device) and from Diasend (from Tandem device). All data will be exported in an excel file.
Demographic and clinical characteristic of enrolled patients (sex, BMI, Zscore BMI), HbA1c) will be collected from their medical records.
Observation period: from the dinner bolus to the next 10 hours of fasting.
Data from glucose sensor:
Endpoints from the sensor data will be evaluated:
Data about insulin dose:
Endpoints from insulin pump will be evaluated:
Data about carbohydrates amount:
Total carbohydrates amount entered during the observation period
Data about automatic mode:
Percentage of time in AutoMode during the observation period
The investigators will compare data of:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 hours
TIR (Time in range:amount of time those with diabetes spend with blood glucose levels between 70 and 180 mg/dl)
Time frame: 10 hours
TBR (Time below range:amount of time those with diabetes spend with blood glucose levels < 70 mg/dl)
Time frame: 10 hours
TAR (Time Above Range: amount of time those with diabetes spend with blood glucose levels >250 mg/dl)
Time frame: 10 hours
TIR (Time in range:amount of time those with diabetes spend with blood glucose levels between 70 and 180 mg/dl)
Time frame: 10 hours
TBR (Time below range:amount of time those with diabetes spend with blood glucose levels < 70 mg/dl)
Time frame: 10 hours
TAR (Time Above Range: amount of time those with diabetes spend with blood glucose levels >250 mg/dl)
University of Campania Luigi Vanvitelli
Other
Comparison of the Glucose Metrics After Eating Pizza Margherita and a Meal Equivalent in Macronutrient in Pediatric Patients With Type 1 Diabetes Mellitus Treated With Hybrid Closed Loop Systems
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03761186
Autoimmune Diseases, Diabetes Mellitus
Stockholm, Sweden
View Trial DetailsNCT05557227
Glucose Metabolism Disorders, Hyperglycemia
Aarhus, Region Midt, Denmark
View Trial DetailsNCT06115616
Type1diabetes
Aarhus, Denmark
View Trial DetailsNCT05662267
Autoimmune Diseases, Chronic Disease
Lille, France
View Trial Details